Geron Corporation (GERN) Issues Quarterly Earnings Results

Share

Geron Corporation (NASDAQ:GERN) reported that the U.S. FDA has granted Fast Track designation to imetelstat for the prospective treatment of adult people with transfusion-dependent anemia following low or Intermediate-1 risk MDS who are non-del and who are resistant or refractory to treatment with an ESA.

Several equities analysts have commented on the stock. Given the stock's recent action, it seemed like a good time to take a closer look at the company's recent data. Zacks Investment Research upgraded Geron Corporation from a "hold" rating to a "buy" rating and set a $2.50 price objective for the company in a research report on Tuesday, October 3rd.

Heading into the stock price potential, Geron Corporation needs to grow just 82.93% to cross its median price target of $3.75. Finally, BidaskClub cut Geron Corporation from a "hold" rating to a "sell" rating in a research note on Saturday, August 5th. The company saw 1.96 million shares trade hands over the course of the day.

Taking a glance at where the stock might be directed in the future, on a consensus basis, the sell-side has a 52 week price target of $3.75 on the stock, this valuation is based on 2 number of opinions.

The company has mean EPS estimate of -0.04 reported by 1 number of analyst for the quarter ending Current Qtr.(Sep2017).

Geron Corporation (NASDAQ:GERN) as of recent trade, has shown weekly upbeat performance of 0.49% which was maintained at -8.07% in 1-month period.

While having a peek at profitability ratios Geron Corporation (NASDAQ:GERN) has trailing twelve month gross margin at 0%, its trailing twelve month operating margin stands at 0% whereas its trailing twelve month net profit margin spots at 0%. The company's forward price to earnings ratio for next fiscal year is 0. The business had revenue of $0.16 million during the quarter, compared to analyst estimates of $0.40 million. The firm's revenue was down 96.8% compared to the same quarter past year. If you are accessing this story on another publication, it was illegally copied and republished in violation of US & global trademark and copyright legislation.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company.

Institutions own 38.80% of Geron Corporation (GERN)'s shares. As of quarter end Aperio Group, LLC had acquired 5,857 shares growing its holdings by 49.3%. The value of the company's investment in Geron Corporation increased from $161,000 to $180,000 a change of 11.8% quarter to quarter. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Geron Corp. discovers and develops therapeutic products for cancer. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity.

Share

Advertisement

Related Posts

Olstein Capital Management LP Reduces Stake in Walt Disney Company (The) (DIS)
It improved, as 77 investors sold DIS shares while 606 reduced holdings. 108 funds opened positions while 638 raised stakes. Moreover, Balyasny Asset Management Limited has 0% invested in Waste Management, Inc. 4,800 are held by Madison Invest Inc.

Securities Analyst Recommendations: Aceto Corporation (ACET), Party City Holdco Inc. (PRTY)
BidaskClub downgraded shares of Aceto Corporation from a buy rating to a hold rating in a research note on Wednesday, July 12th. Following the transaction, the chief operating officer now directly owns 72,817 shares in the company, valued at $769,675.69.

Alabama Freshman QB Arrested on DUI Charges
We will further evaluate what actions we need to take moving forward so we can correct the behavior. Jones is one of the Crimson Tide's two freshmen quarterbacks, along with backup QB Tua Tagovailoa.

Telemark Asset Management LLC Increases Position in Pioneer Nat Res Co (PXD)
Out of 34 Wall Street analysts rating Pioneer Natural Resources, 30 give it "Buy", 1 "Sell" rating, while 3 recommend "Hold". Cullen Frost Bankers Inc decreased Vanguard Growth Etf (VUG) stake by 4,153 shares to 106,907 valued at $13.58M in 2017Q2.

Deepika, Abhishek to appear in Bhansali's Sahir Ludhianvi biopic
Amitabh Bachchan has worked with the lyricist in the movies like "Trishul" and "Kabhi Kabhi", so he might be able to help him. Deepika will be playing the role of famous poetess Amrita Pritam, the role which PC was supposed to play initally.

Sen. Elizabeth Warren punches back at Trump on Twitter
On Thursday's The Larry O'Connor Show, the commander in chief said "the saddest thing" about being president is that he is not supposed to give orders to the Justice Department or Federal Bureau of Investigation .

Mila Kunis makes monthly donation to Planned Parenthood
She's not the only celebrity to donate to Planned Parenthood in Pence's name. Kunis has been outspoken in her disdain for Trump. Kunis continued, "I don't look at it as a prank".

Trump again urges death penalty for NYC suspect
Detainees at Guantanamo accused of supporting militants have faced military tribunals, rather than trials in the USA legal system. Declaring Saipov an enemy combatant would have allowed investigators to interrogate him without having a lawyer present.

ED issues notice to Yasin Malik
The four-page notice mentioned that the complaint was received on 25 October. JKLF chief was later arrested but subsequently relased on bail.

Second Libyan militant charged in 2012 Benghazi attacks appears in USA court
He was charged with three felony offenses, two of which carry a maximum sentence of life imprisonment. Al-Imam is the second suspect in the attacks to have been captured by the USA and brought to court.

© 2015 ExpressNewsline. All Rights reserved.